Publications by authors named "Taube C"

Background: Using primary airway epithelial cells (AEC) is essential to mimic more closely different types and stages of lung disease in humans while reducing or even replacing animal experiments. Access to lung tissue remains limited because these samples are generally obtained from patients who undergo lung transplantation for end-stage lung disease or thoracic surgery for (mostly) lung cancer. We investigated whether forceps or cryo biopsies are a viable alternative source of AEC compared to the conventional technique.

View Article and Find Full Text PDF

Background: Non-malignant chronic diseases remain a major public health concern. Given the alterations in lipid metabolism and deposition in the lung and its association with fibrotic interstitial lung disease (fILD) and chronic obstructive pulmonary disease (COPD), this study aimed to detect those alterations using computed tomography (CT)-based analysis of pulmonary fat attenuation volume (CTpfav).

Methods: This observational retrospective single-center study involved 716 chest CT scans from three subcohorts: control (n = 279), COPD (n = 283), and fILD (n = 154).

View Article and Find Full Text PDF
Article Synopsis
  • Targeted therapies using biologics for atopic diseases, urticaria, and angioedema are advancing quickly, with several new antibodies developed, tested, and approved for clinical use, like omalizumab and dupilumab.
  • There is ongoing research into combining different biologics for enhanced treatment efficacy, expanding their applications to conditions like food allergies and eosinophilic esophagitis.
  • There are emerging concerns about unexpected side effects and hypersensitivity reactions associated with these therapies, raising important questions about their safety and mechanisms, particularly in specific patient groups like children.
View Article and Find Full Text PDF

During the annual conference of the German Respiratory Society (DGP = Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin) in 2024, updated recommendations for lung function testing have been published. The original full-length version can be downloaded free of charge as pfd-paper from the journal entitled "Atemwegs- und Lungenkrankheiten, Jahrgang 50 (2024) März (111-184)". In the current recommendations new approaches have been embedded that focus on modern interpretations of lung function results, as has been proposed by the ERS (European Respiratory Society) in collaboration with the ATS (American Thoracic Society).

View Article and Find Full Text PDF

Background: Hypersensitivity to odorants like perfumes can induce or promote asthma with non-type 2 inflammation for which therapeutic options are limited. Cell death of primary bronchial epithelial cells (PBECs) and the release of the pro-inflammatory cytokines interleukin-6 (IL-6) and IL-8 are key in the pathogenesis. Extra-nasal olfactory receptors (ORs) can influence cellular processes involved in asthma.

View Article and Find Full Text PDF

Cystic fibrosis bone disease (CFBD) is a common comorbidity in adult people with cystic fibrosis (pwCF), resulting in an increased risk of bone fractures. This study evaluated the capacity of artificial intelligence (AI)-assisted low-dose chest CT (LDCT) opportunistic screening for detecting low bone mineral density (BMD) in adult pwCF. In this retrospective single-center study, 65 adult pwCF (mean age 30.

View Article and Find Full Text PDF

Respiratory syncytial virus (RSV) is a seasonal virus known to cause significant morbidity in pediatric patients; however, morbidity in adult patients has not been well investigated. We aimed to characterize adult patients with RSV infection in the emergency department (ED) and their clinical course. During the winter term 2022/23, all adult ED patients were screened for RSV, severe acute respiratory syndrome coronavirus type 2, and influenza infection using point-of-care polymerase chain reaction tests.

View Article and Find Full Text PDF
Article Synopsis
  • Regular disease monitoring in cystic fibrosis patients is essential, and this study compared low-dose high-resolution (LD-HR) CT scans using photon-counting CT (PCCT) versus energy-integrating detector system CT (EID-CT).
  • The results showed that PCCT reduced radiation exposure by about 42% and had superior image quality and sharpness compared to EID-CT.
  • Ultimately, PCCT proved to be a more advantageous method for monitoring cystic fibrosis due to its lower radiation dose and improved imaging capabilities.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze seasonal patterns of respiratory viruses in both immunocompetent and immunosuppressed patients, focusing on five specific viruses.
  • A retrospective analysis of 13,591 samples revealed distinct seasonal trends for each virus, with HMPV peaking from January to March, RSV from December to March, and influenza primarily in January and February.
  • The findings showed no significant difference in the seasonal patterns of these viruses between immunocompromised and healthy individuals.
View Article and Find Full Text PDF

Chronic infection with Schistosoma mansoni parasites is associated with reduced allergic sensitization in humans, while schistosome eggs protects against allergic airway inflammation (AAI) in mice. One of the main secretory/excretory molecules from schistosome eggs is the glycosylated T2-RNAse Omega-1 (ω1). We hypothesized that ω1 induces protection against AAI during infection.

View Article and Find Full Text PDF

Background: The Asthma Impairment and Risk Questionnaire (AIRQ), a 10-item, equally weighted, yes/no tool assessing symptom impairment and risk of exacerbations in patients with asthma aged ≥12 years, was developed and validated in a US patient population to evaluate varying levels of asthma control. This study aimed to validate the German language version of the AIRQ in patients aged ≥12 years with different levels of asthma control.

Methods: A cross-sectional, observational, multi-centre study comprising a single visit was conducted in multiple specialised asthma centres and general practices in Germany.

View Article and Find Full Text PDF

(Im)P-P(Dipp)˙ (1˙), a rare example of a neutral, mixed substituted diphosphene radical, has been prepared by reduction of (Im)PP(Dipp)[OTf] (2[OTf]) and (Im)PP(Cl)(Dipp) (3) with cobaltocene (CoCp) (Im = 4,5-dichloro-1,3-bis(1,3-diisopropylphenyl)-imidazol-2-yl, Dipp = 2,6-diisopropylphenyl). Radical compound 1˙ readily activates white phosphorus (P), resulting in the formation of an intriguing octaphosphane butterfly compound P(Im)(Dipp) (4).

View Article and Find Full Text PDF
Article Synopsis
  • Elexacaftor/tezacaftor/ivacaftor (ETI) treatment for cystic fibrosis can lead to liver-related side effects, particularly in patients with Gilbert's syndrome, a genetic condition that elevates bilirubin levels.
  • A case series involving six cystic fibrosis patients revealed that Gilbert's syndrome was often unmasked after starting ETI, causing varying degrees of hepatic dysfunction but allowing most to continue treatment, some at adjusted dosages.
  • Physicians should recognize that while Gilbert's syndrome may seem like a risk factor for liver issues during ETI therapy, it is not a reason to stop treatment, and patients can still benefit from ETI despite liver-related complications.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how pre-biologic biomarker levels, specifically immunoglobulin E (IgE), blood eosinophil count (BEC), and fractional exhaled nitric oxide (FeNO), influence asthma treatment outcomes when patients start biologic therapy.
  • Conducted across 23 countries with over 3750 patients, the research focused on changes in exacerbation rates, symptom control, and lung function about a year after starting treatment.
  • Results showed that higher levels of BEC and FeNO were linked to significant improvements in lung function for specific biologic therapies, while IgE was not a strong predictor of treatment effectiveness.
View Article and Find Full Text PDF

Bronchoscopic lung volume reduction (BLVR) with endobronchial valves has been shown to be a safe and effective treatment for patients with severe lung emphysema. Previous studies have reported a benefit in pulmonary function, exercise capacity, and quality of life after BLVR-treatment. The effect of BLVR with valves on the pulmonary gas exchange and its association with clinical outcomes has not been analyzed to date.

View Article and Find Full Text PDF
Article Synopsis
  • Poor nutritional status negatively impacts lung function and survival in people with cystic fibrosis (pwCF).
  • A study using deep-learning analyzed body composition changes in 66 adults with CF before and after elexacaftor/tezacaftor/ivacaftor (ETI) therapy, finding significant increases in adipose tissue but only minimal improvements in muscle ratio.
  • The results indicate that ETI therapy mainly influences fat tissue, particularly in underweight patients, which may inform future nutritional strategies for managing CF.
View Article and Find Full Text PDF

Chronic Obstructive Pulmonary Disease (COPD) is characterized by progressive and irreversible airflow limitation, with individual body composition influencing disease severity. Severe emphysema worsens symptoms through hyperinflation, which can be relieved by bronchoscopic lung volume reduction (BLVR). To investigate how body composition, assessed through CT scans, impacts outcomes in emphysema patients undergoing BLVR.

View Article and Find Full Text PDF

Background: Therapeutic options for steroid-resistant non-type 2 inflammation in obstructive lung diseases are limited. Bronchial epithelial cells are key in the pathogenesis by releasing the central proinflammatory cytokine interleukine-8 (IL-8). Olfactory receptors (ORs) are expressed in various cell types.

View Article and Find Full Text PDF

Background: Monoclonal antibodies (biologics) drastically changed severe asthma therapy. Mepolizumab (anti-interleukin (IL) 5), benralizumab (anti-IL5 receptor alpha), and dupilumab (anti-IL4/13) are the most used biologics in this context. While all biologics are efficient individually, the choice of biologic is complicated by insufficient data on their comparative long-term treatment efficacy.

View Article and Find Full Text PDF
Article Synopsis
  • Maintaining physical fitness is crucial for adults with cystic fibrosis (pwCF), but there is limited data on how new therapies like ETI affect their fitness levels over time.
  • A study tracked 28 adult pwCF for about 5.6 years, measuring various physical fitness components and health indicators like BMI and FEV1, finding significant improvements in BMI and some health-related fitness measures after starting ETI therapy.
  • While ETI therapy showed some positive effects, the overall impact on fitness was small, suggesting that other factors also play a role in achieving high physical fitness in pwCF.
View Article and Find Full Text PDF